Virtual Reality-Assisted Nursing Intervention During Intrauterine Device Insertion (VR-IUD)
Effect of Virtual Reality-Assisted Nursing Intervention on Pain and Anxiety During Intrauterine Device Insertion: A Randomized Controlled Trial
This randomized controlled trial evaluated the effects of a virtual reality-supported nursing intervention based on Kolcaba's Comfort Theory on women's comfort, emotional state, pain and physiological parameters during intrauterine device insertion. Seventy women attending a family planning clinic were individually randomized by lottery to a virtual reality group, who received the intervention in addition to routine care, or to a control group, who received routine care only.
Visão geral do estudo
Status
Status
Condições
Condições
Intervenção / Tratamento
Intervenção / Tratamento
Descrição detalhada
Study hypotheses
Compared with the control group (routine care without virtual reality), women receiving the virtual reality-assisted nursing intervention (experimental group):
- experience a lower level of pain during the procedure;
- experience lower levels of anxiety during the procedure;
- exhibit a lower stress response in physiological parameters (pulse rate, blood pressure and respiratory rate);
- experience higher levels of comfort during the procedure. Condition: Pain, anxiety, physiological parameters and comfort of women during intrauterine device (IUD) insertion Intervention: Virtual reality-assisted nursing intervention Population: Women who have decided to have an IUD inserted Note on outcomes: In the initial registration, pain was erroneously listed as the primary outcome. The primary outcome of this trial is overall comfort, measured with the General Comfort Scale total score before and after the procedure. This was corrected on October 30, 2026. Pain was assessed at all planned time points and is reported as a secondary outcome.
Study Design Study type: Interventional (clinical trial) Design: Single-center, prospective, two-arm, parallel-group randomized controlled trial Allocation: Randomized (1:1) Masking: None (open label). Because of the nature of the intervention, participants, the nurse researcher delivering the intervention and the practitioners could not be blinded. Data were coded before analysis, and the analyses were performed by a researcher who was not involved in data collection.
Setting: Family planning outpatient clinic of a women's and children's hospital, Gaziantep, Türkiye Study period: October 2024 to March 2025 Sample Size The sample size was calculated with G*Power 3.1.9.4 for a repeated-measures analysis of variance (two groups, two measurements), with a significance level of 5% (alpha = 0.05), a power of 95% and an effect size of f = 0.40. The minimum required sample was 64 women (32 per group). To allow for possible data loss, the target sample was set at 70 women (35 per group).
Participant Flow Eighty-nine women who agreed to participate were assessed for eligibility. Nineteen did not meet the eligibility criteria (visual impairment, n = 5; psychiatric disorder, n = 2; severe dizziness, n = 4; analgesic use before the procedure, n = 8). The remaining 70 women were randomized (experimental group = 35, control group = 35). No participant withdrew or was lost to follow-up, and all 70 women were included in the analysis.
Randomization and Groups Participants were individually randomized in a 1:1 ratio to the experimental or control group by lottery. Seventy identical slips of white paper, 35 labeled "experimental group" and 35 labeled "control group," were placed in a bag. After giving written informed consent and completing the baseline assessments, and before IUD insertion, each eligible woman drew one slip from the bag; drawn slips were not returned.
Given the nature of the intervention, information exchange between participants (contamination) could have influenced the results. To minimize this risk, women waited in a separate waiting area before the procedure, were called into the procedure room individually and, after the procedure, left the clinic through a separate exit that did not lead back to the waiting area.
Baseline characteristics of the groups were compared statistically, and baseline-adjusted analyses were used to account for any imbalances.
Note: An earlier version of this record described day-based allocation. This description has been corrected to reflect the individual lottery-based randomization that was actually implemented.
Intervention Experimental group (virtual reality group): In addition to routine care, women received a virtual reality-assisted nursing intervention based on Kolcaba's Comfort Theory. The nurse researcher prepared each woman for the procedure and used virtual reality to increase her comfort and reduce her anxiety. Women watched a nature-themed 360-degree video (water, forest and sky scenes) with soothing music, lasting approximately 6 minutes, through a virtual reality headset. The video was started 2 minutes before insertion and continued until it ended after insertion. The intervention was designed as a non-pharmacological nursing intervention to divert attention away from the procedure and to reduce pain and anxiety.
Control group (routine care): Women received routine care according to the clinic's standard practice, without virtual reality or any other study intervention.
All participants received a copper IUD inserted by the practitioners on duty. Materials
- Virtual reality headset: Samsung Gear VR (SM-R321NZWATUR), used with a smartphone
- Virtual reality video: "Virtual Nature 360° - 5K Nature Meditation for Daydream, Oculus, Gear VR," featuring nature scenes accompanied by calming music Data Collection Data were collected by trained researchers through face-to-face interviews in three phases; each session took approximately 15 to 20 minutes.
Before the procedure: Descriptive Characteristics Questionnaire; General Comfort Scale; visual analogue scales for anticipated pain, tension, fear/anxiety, irritability and contentment; blood pressure, pulse rate and respiratory rate. Allocation slips were drawn after these assessments.
During the procedure: pain (visual analogue scale) and pulse rate immediately after speculum insertion, tenaculum application and IUD placement.
After the procedure (5 minutes): blood pressure, pulse rate and respiratory rate; visual analogue scales for pain, tension, fear/anxiety, irritability and contentment; General Comfort Scale. Procedure duration (minutes), practitioner satisfaction and adverse events (such as dizziness, nausea and headset discomfort) were also recorded.
Vital signs were measured in both groups by the same researcher with the same device.
Data Collection Instruments Descriptive Characteristics Questionnaire: Prepared by the researchers on the basis of the literature; it covers age, education, employment, income, health insurance, obstetric history, current contraceptive use and its duration, previous IUD use, the person who decided on IUD use and negative information about IUDs received from the social environment.
General Comfort Scale: Developed by Kolcaba and adapted into Turkish, the scale consists of 48 four-point Likert-type items in three subscales (relief, ease and transcendence). Negative items are reverse-scored. Total scores range from 48 to 192, and higher scores indicate greater comfort. Cronbach's alpha was 0.85 for the Turkish version.
Visual analogue scales: Tension, fear/anxiety, irritability and contentment were each rated on a 100-mm scale from 0 (none) to 100 (most intense). Pain was rated on a 100-mm scale from 0 (no pain) to 100 (worst imaginable pain). Before the procedure, women rated on the same scale the pain they expected to feel during insertion (anticipated pain). The practitioner rated satisfaction with the procedure on a 100-mm scale from 0 (not at all satisfied) to 100 (completely satisfied).
Ethics Ethical approval was obtained from the SANKO University Clinical Research Ethics Committee (Decision No. 2023/24; December 21, 2023), together with institutional permission. The study followed the Declaration of Helsinki. Participants were informed about the aims and procedures of the study, and written informed consent was obtained from all participants.
Statistical Analysis Data were analyzed with IBM SPSS Statistics 25.0. Normality was assessed by skewness and kurtosis, homogeneity of variances by Levene's test and homogeneity of covariance matrices by Box's M test. Baseline characteristics were compared with the chi-square, Fisher's exact or Fisher-Freeman-Halton exact test and the independent-samples t-test, and standardized mean differences were calculated.
Intervention effects were estimated with analysis of covariance (ANCOVA), using the post-procedure score as the dependent variable, group as the fixed factor and the baseline score as the covariate (anticipated pain for pain after the procedure). ANCOVA assumptions (linearity, homogeneity of regression slopes, normality and homogeneity of residuals, influential observations) were checked. Sensitivity analyses included additional covariates for imbalanced baseline characteristics, heteroscedasticity-consistent (HC3) standard errors and a mixed-design repeated-measures ANOVA (group x time).
Variables not suitable for parametric testing (irritability, pain, procedure duration and practitioner satisfaction) were compared with the Mann-Whitney U test, and within-group change in pain with the Wilcoxon signed-rank test. Intraprocedural pain was compared with the Mann-Whitney U test and intraprocedural pulse rate with ANCOVA adjusted for baseline pulse rate. All tests were two-sided, and p < 0.05 was considered significant.
Tipo de estudo
Tipo de estudo
Inscrição (Real)
Inscrição
Estágio
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Gaziantep, Turquia (Türkiye), 27270
- Women's and Children's Hospital
-
-
Critérios de participação
Critérios de elegibilidade
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
Aged 18 years or older Sexually active Decided to undergo intrauterine device insertion after routine contraceptive counseling Suitable candidate for intrauterine device insertion on gynecological examination No communication difficulties
Exclusion Criteria:
Visual or hearing impairment Diagnosed psychiatric disorder Severe facial injury History of epilepsy or severe dizziness Analgesic use before the procedure Any contraindication to intrauterine device insertion
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Número de braços
Armas e Intervenções
Grupo de Participantes / BraçoGrupo de Participantes / Braço |
Intervenção / TratamentoIntervenção / Tratamento |
|---|---|
|
Experimental: Virtual reality group
Intervention Type: Behavioral Intervention Name: Virtual reality-supported nursing intervention Other Intervention Names: VR-supported nursing intervention Assign to Arm: Experimental: Virtual reality group Description:Routine care plus the virtual reality-supported nursing intervention during IUD insertion. In addition to routine care, women received a virtual reality-supported nursing intervention based on Kolcaba's Comfort Theory. The nurse prepared each woman for the procedure and used virtual reality to increase comfort and reduce anxiety. Women watched a nature-themed 360-degree video with relaxing music (approximately 6 minutes) through a head-mounted display (Samsung Gear VR), started 2 minutes before insertion and continued until the video ended. |
Intervention Name: Virtual Reality Intervention Description: Participants in the experimental group received a virtual reality-assisted nursing intervention during intrauterine device insertion. A virtual reality headset was used to present a 3D immersive video including relaxing natural scenes and calming background music. The intervention was applied continuously throughout the procedure to distract attention from the procedure and reduce pain and anxiety. Intervention Name: Routine Care Description: Participants in the control group received routine care during intrauterine device insertion without the use of virtual reality or any additional distraction method. |
|
Sem intervenção: Control Group
Arm Title Control group Arm Type No Intervention Arm Description Routine care according to the clinic's standard practice, without virtual reality or any other study intervention. |
O que o estudo está medindo?
Medidas de resultados primários
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
General Comfort Scale total score
Prazo: Before IUD insertion (baseline) and 5 minutes after the procedure
|
Overall comfort was measured with the Turkish version of Kolcaba's General Comfort Scale, which consists of 48 items rated on a four-point Likert scale. Total scores range from 48 to 192, with higher scores indicating greater comfort. |
Before IUD insertion (baseline) and 5 minutes after the procedure
|
Medidas de resultados secundários
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
General Comfort Scale subscale scores (relief, ease and transcendence)
Prazo: Before IUD insertion (baseline) and 5 minutes after the procedure
|
Scores of the relief, ease and transcendence subscales of the General Comfort Scale; higher scores indicate greater comfort. |
Before IUD insertion (baseline) and 5 minutes after the procedure
|
|
Emotional state scores (tension, fear/anxiety, irritability and contentment)
Prazo: Before IUD insertion (baseline) and 5 minutes after the procedure
|
Each emotional state was rated on a single-item 100-mm visual analog scale ranging from 0 (none) to 100 (most intense). |
Before IUD insertion (baseline) and 5 minutes after the procedure
|
|
Pain intensity (visual analog scale)
Prazo: Before the procedure (anticipated pain); immediately after speculum insertion, tenaculum application and IUD placement; and 5 minutes after the procedure
|
Pain was rated on a 100-mm visual analog scale from 0 (no pain) to 100 (worst imaginable pain). Before the procedure, women rated the pain they expected to feel during insertion (anticipated pain). |
Before the procedure (anticipated pain); immediately after speculum insertion, tenaculum application and IUD placement; and 5 minutes after the procedure
|
|
Pulse rate (beats per minute
Prazo: Before the procedure; immediately after speculum insertion, tenaculum application and IUD placement; and 5 minutes after the procedure
|
Pulse rate was measured by the same researcher with the same device in both groups. |
Before the procedure; immediately after speculum insertion, tenaculum application and IUD placement; and 5 minutes after the procedure
|
|
Respiratory rate (breaths per minute)
Prazo: Before the procedure and 5 minutes after the procedure
|
Respiratory rate was counted by the same researcher in both groups. |
Before the procedure and 5 minutes after the procedure
|
|
Systolic and diastolic blood pressure (mmHg)
Prazo: Before the procedure and 5 minutes after the procedure
|
Blood pressure was measured by the same researcher with the same device in both groups. |
Before the procedure and 5 minutes after the procedure
|
|
Duration of IUD insertion (minutes
Prazo: During the procedure
|
Time from the start to the end of the insertion procedure, recorded by the researcher in whole minutes. |
During the procedure
|
|
Practitioner satisfaction with the procedure
Prazo: Immediately after the procedure
|
The practitioner performing the insertion rated overall satisfaction with the procedure on a single-item 100-mm visual analog scale from 0 (not at all satisfied) to 100 (completely satisfied). |
Immediately after the procedure
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Investigadores
Investigadores
- Cadeira de estudo: Emine BAŞ, PhD, Sanko University
- Cadeira de estudo: Zeynep GÜNGÖRMÜŞ, Prof, Gaziantep Islam Science and Technology University
- Investigador principal: Yasemin ATEŞEYAN, PhD, MERSİN UNIVERSITY
- Cadeira de estudo: Esra VERİM, PhD, GAZİANTEP UNIVERSITY
Publicações e links úteis
Publicações Gerais
- Aydın, A., Araz, A., Asan, A. 2011. Görsel Analog Ölçeği ve Duygu Kafesi: Kültürümüze Uyarlama Çalışması, Türk Psikoloji Yazıları,14 (27), 1-13.
- Kolcaba, K. (2003). Comfort Theory and Practice A vision for holistik health care and research, Springer Publishing Company. New York
- Kuğuoğlu, S., & Karabacak, Ü. (2008). Genel Konfor Ölçeğinin Türkçe 'ye uyarlanması. İstanbul Üniversitesi Florence Nightingale Hemşirelik Yüksekokulu Dergisi, 61(16), 16-23.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Início do estudo
Conclusão Primária (Real)
Conclusão Primária
Conclusão do estudo (Real)
Conclusão do estudo
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Primeira postagem
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última Atualização Postada
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
Outros números de identificação do estudo
- SANKO UNIVERSITY
- YASEMİN ATEŞEYAN (Identificador de registro: VR-IUD)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Data are available from the corresponding author upon reasonable request because of privacy and ethical restrictions.
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .